BCR-ABL-IN-13

Customer Review

Based on 1 Customer Validation

BCR-ABL-IN-13 is a dual c-Src and Abl inhibitor, with a Ki value of 0.55 μM against c-Src, 0.10 μM against wild-type Abl, and 0.40 μM against the AblT315I mutant. BCR-ABL-IN-13 exerts competitive/mixed-type inhibitory effects on wild-type Abl, and non-competitive inhibitory effects on the drug-resistant AblT315I mutant. BCR-ABL-IN-13 can be used for the research of chronic myeloid leukemia.

For research use only. We do not sell to patients.

  • Purity: 99.86%
  • CAS No.: 607702-99-8
  • Formula: C16H11F2N3OS2
  • Molecular Weight:363.40
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Src Isoforms

More

All Bcr-Abl Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00